Related references
Note: Only part of the references are listed.Fibroblast growth factor 21 in heart failure
William Tucker et al.
HEART FAILURE REVIEWS (2023)
Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction
Liuzhang Fan et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2022)
Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
Guihai Wu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
Francesco Baratta et al.
ATHEROSCLEROSIS (2022)
FGF21-Srtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity
Leigang Jin et al.
CIRCULATION (2022)
DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism
Nozomi Furukawa et al.
HEART AND VESSELS (2021)
Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy
Lingyun Gu et al.
CARDIOLOGY (2021)
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis
Yucong Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification
Feng Gan et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer et al.
CELL METABOLISM (2019)
FGF19 subfamily members: FGF19 and FGF21
Katarzyna Dolegowska et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
Kwok Leung Ong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms
Soravis Osataphan et al.
JCI INSIGHT (2019)
Serum FGF21 Is Associated with Future Cardiovascular Events in Patients with Coronary Artery Disease
Yun Shen et al.
CARDIOLOGY (2018)
Liver Plays a Major Role in FGF-21 Mediated Glucose Homeostasis
Mingyao Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
Ishan Lakhani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
Chi Ho Lee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Associations of fibroblast growth factor 21 with cardiovascular risk and β-cell function in patients who had no history of diabetes
Jun-Sing Wang et al.
CLINICA CHIMICA ACTA (2017)
Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death
Yun Shen et al.
CARDIOVASCULAR DIABETOLOGY (2017)
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
Saswata Talukdar et al.
CELL METABOLISM (2016)
Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
Qing Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
Zhuofeng Lin et al.
CIRCULATION (2015)
Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway
Chi Zhang et al.
DIABETOLOGIA (2015)
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Fibroblast growth factor 21 protects the heart from oxidative stress
Anna Planavila et al.
CARDIOVASCULAR RESEARCH (2015)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
Raul Herzog et al.
BMC PUBLIC HEALTH (2013)
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
Yun Shen et al.
CARDIOVASCULAR DIABETOLOGY (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
Y. C. Woo et al.
CLINICAL ENDOCRINOLOGY (2013)
Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up
M. Lenart-Lipinska et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
A. Planavila et al.
NATURE COMMUNICATIONS (2013)
Mechanisms of FGFR-mediated carcinogenesis
Imran Ahmad et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones
Paul A. Dutchak et al.
CELL (2012)
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
Murielle M. Veniant et al.
PLOS ONE (2012)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice
Xiaofan Li et al.
FEBS LETTERS (2009)
Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states
Michael K. Badman et al.
CELL METABOLISM (2007)
Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21
Takeshi Inagaki et al.
CELL METABOLISM (2007)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Share Paper
